Embed
Email

2116134pdf

Document Sample

Shared by: Peter Crisp
Categories
Tags
Stats
views:
3
posted:
9/4/2009
language:
pages:
2
MATERIAL SAFETY DATA SHEET



PRODUCT NAME:



Gentamicin 100 mg/ml



MANUFACTURED FOR BUTLER BY WALNUT PHARMACEUTICALS



A Service of



- - - - - - - - - - - - - - - - MATERIAL SAFETY DATA SHEET - - - - - - - - - - - - - - Walnut Pharmaceuticals

----------------------------------------------------------I. PRODUCT IDENTIFICATION ----------------------------------------------------------TRADE NAME: AK - GENT GENTAMICIN OPHTHALMIC SOLUTION COMMON NAME: Gentamicin Ophthalmic Solution, USP MANUFACTURER: WALNUT PHARMACEUTICALS INC. 20510 EARLGATE STREET WALNUT, CA 91789 (714) 598-6504 REV.: 1/5/90 ----------------------------------------------------------II. HAZARDOUS INGREDIENTS ----------------------------------------------------------None ----------------------------------------------------------II A. INGREDIENTS ----------------------------------------------------------CHEMICAL NAMES/ CAS NUMBERS PERCENT OSHA ACGIH OTHER ----------------------------------------------------------Gentamicin as Sulfate 0.3 Unknown 1403-66-3 Monosodium Phosphate 0.01 Unknown 7558-80-7 Disodium Phosphate 0.29 Unknown 7558-79-4 Sodium Chloride 0.74 Unknown 7647-14-5 Benzalkonium Chloride 0.01 Unknown Not Applicable ----------------------------------------------------------III. PHYSICAL PROPERTIES ----------------------------------------------------------VAPOR DENSITY (Air=1): No Data SPECIFIC GRAVITY: 1 SOLUBILITY IN WATER: soluble MELTING POINT: N.A. BOILING POINT: ~ 100 deg C VAPOR PRESSURE, MM HG @ 20 DEG C: No Data EVAPORATION RATE BUTYL ACETATE=1: No Data APPEARANCE & ODOR: Clear Colorless Aqueous Solution ----------------------------------------------------------IV. FIRE & EXPLOSION ----------------------------------------------------------FLASH POINT: No data FLAMMABLE LIMITS IN AIR: N.A. FIRE EXTINGUISHING MATERIALS: N.A. SPECIAL FIRE FIGHTING PROCEDURES: N.A. ----------------------------------------------------------V. HEALTH HAZARD INFORMATION ----------------------------------------------------------ORAL: No data DERMAL: Non Irritating INHALATION: No Data EYE CONTACT: Non Irritating, Intended for treatment of eye infections HEALTH EFFECTS OR RISKS FROM EXPOSURE: ACUTE: Essentially non irritating to skin. SWALLOWED: No Data CHRONIC: No Data FIRST AID: EMERGENCY PROCEDURES: EYE CONTACT: Flush with water for 15 minutes. Consult a physician. SKIN CONTACT: Consult a physician if irritation occurs and persists. INHALATION: If breathing is difficult, administer oxygen. If breathing has stopped, administer artificial respiration. SWALLOWING: If conscious and alert, give several glasses of water. CARCINOGENICITY: This material is not considered to be a carcinogen by The National Toxicology Program, The International Agency for Research on Cancer, or The Occupational Safety and Health Administration. OTHER DATA: N.A.



AK - GENT GENTAMICIN OPHTHALMIC SOLUTION

----------------------------------------------------------VI. REACTIVITY DATA ----------------------------------------------------------STABILITY: Stable CONDITIONS TO AVOID: No Data HAZARDOUS DECOMPOSITION PRODUCTS: Carbon Monoxide, Carbon Dioxide, Nitrogen Oxides POLYMERIZATION: will not occur ----------------------------------------------------------VII. SPILL, LEAK, AND DISPOSAL PROCEDURES ----------------------------------------------------------Sweep or vacuum, rinse with water. ----------------------------------------------------------VIII. SPECIAL HANDLING INFORMATION ----------------------------------------------------------RESPIRATORY PROTECTION: Not Required EYE PROTECTION: Goggles Recommended GLOVES: Chemical work gloves not required SPECIAL EQUIPMENT: Not Required HANDLING AND STORAGE: Store at Room Temperature, Protected from Light ----------------------------------------------------------The information contained herein is provided in good faith and is believed to be correct as of the date hereof. However, WALNUT Pharmaceuticals Inc. makes no representation as to the comprehensiveness or accuracy of the information. It is expected that individuals receiving the information will exercise their independent judgement in determining its appropriateness for a particular purpose. Accordingly, WALNUT Pharmaceuticals Inc., will not be responsible for damages of any kind resulting from the use or reliance upon such information. NO REPRESENTATIONS, OR WARRANTIES, EITHER EXPRESSED OR IMPLIED, OF MECHANIABILITY, FITNESS FOR A PARTICULAR PURPOSE OR OF ANY OTHER NATURE ARE MADE HEREUNDER WITH RESPECT TO THE INFORMATION SET FORTH HEREIN THE PRODUCT TO WHICH THE INFORMATION REFERS. ----------------------------------------------------------DISCLAIMER OF EXPRESSED AND IMPLIED WARRANTIES: Although reasonable care has been taken in the preparation of this document, we extend no warranties and make no representation as to the accuracy or completeness of the information contained therein, and assume no responsibility regarding the suitability of this information for the user's intended purposes or for the consequences of its use. Each individual should make a determination as to the suitability of the information for their particular purpose(s). A request has been made to the manufacturer to approve the contents of this material safety data sheet. Upon receipt a new MSDS will be made available. ----------------------------------------------------------COMPAS Code: 14580040



Page 1 of 1




Related docs
Other docs by Peter Crisp
1256045pdf
Views: 0  |  Downloads: 0
00069737
Views: 0  |  Downloads: 0
20-mp7Q2003
Views: 0  |  Downloads: 0
35-mp7G2001
Views: 0  |  Downloads: 0
3685005pdf
Views: 0  |  Downloads: 0
28-avitrol-m
Views: 2  |  Downloads: 0
386-CFFPM
Views: 1  |  Downloads: 0
6075002pdf
Views: 0  |  Downloads: 0
666-mp812001
Views: 0  |  Downloads: 0
4689065pdf
Views: 0  |  Downloads: 0